Insulin sensitivity and plasma homocysteine concentrations in non-diabetic obese and normal weight subjects

Atherosclerosis

Volumn 167, Issue 1, 2003, Pages 105-109

  Fonseca, Vivian A ^a,c   Fink, Louis M ^b   Kern, Philip A ^b  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Homocysteine; Insulin sensitivity; Obesity

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; GLUCOSE; HOMOCYSTEINE; INSULIN;

ADULT; ANALYSIS; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYANOCOBALAMIN DEFICIENCY; DIABETES MELLITUS; FEMALE; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LEAN BODY WEIGHT; LINEAR REGRESSION ANALYSIS; MALE; MEASUREMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RISK FACTOR; SAMPLE; VASCULAR DISEASE; VITAMIN BLOOD LEVEL; VITAMIN DEFICIENCY;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE TOLERANCE TEST; HOMOCYSTEINE; HUMANS; INSULIN RESISTANCE; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PROBABILITY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 0037372930     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00386-6     Document Type: Article

References (28)

1. Eikelboom J.W., Lonn E., Genest J.J., Hankey G., Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Annals of Internal Medicine. 131:1999;363-375. see comments, review, 95 references.
2. Hoogeveen E.K., Kostense P.J., Jakobs C., et al. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the hoorn study. Circulation Research. 101:2000;1506-1511.
3. Stehouwer C.D., Gall M.A., Hougaard P., Jakobs C., Parving H.H. Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria. Kidney International. 55:1999;308-314.
4. Kark J.D., Selhub J., Bostom A., Adler B., Rosenberg I.H. Plasma homocysteine and all-cause mortality in diabetes. Lancet. 353:1999;1936-1937. letter.
5. Munshi M.N., Stone A., Fink L., Fonseca V. Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease. Metabolism: Clinical and Experimental. 45:1996;133-135.
6. Reaven G.M. The role of insulin resistance and hyperinsulinemia in coronary heart disease. Metabolism: Clinical and Experimental. 41:1992;16-19. review, 30 references.
7. Lussier-Cacan S., Xhignesse M., Piolot A., Selhub J., Davignon J., Genest J.J. Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. American Journal of Clinical Nutrition. 64:1996;587-593. see comments.
8. Jacobsen D.W. Determinants of hyperhomocysteinemia: a matter of nature and nurture. American Journal of Clinical Nutrition. 64:1996;641-642. editorial, comment.
9. Fonseca V., Guba S.C., Fink L.M. Hyperhomocysteinemia and the endocrine system: implications for atherosclerosis and thrombosis. Endocrine Reviews. 20:1999;738-759.
10. Fonseca V.A., Mudaliar S., Schmidt B., Fink L.M., Kern P.A., Henry R.R. Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects. Metabolism: Clinical and Experimental. 47:1998;686-689.
11. Jacobs R.L., House J.D., Brosnan M.E., Brosnan J.T. Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat. Diabetes. 47:1998;1967-1970.
12. Fonseca V., Dicker-Brown A., Ranganathan S., et al. Effects of a high-fat-sucrose diet on enzymes in homocysteine metabolism in the rat. Metabolism. 49:2000;736-741.
13. Bergman R.N., Finegood D.T., Ader M. Assessment of insulin sensitivity in vivo. Endocrine Reviews. 6:1985;45-86. review, 244 references.
14. Bergman R.N., Prager R., Volund A., Olefsky J.M. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. Journal of Clinical Investigation. 79:1987;790-800.
15. Ubbink J., Hayward V.W., Bissport S. Rapid high performance liquid chromatographic assay for total homocysteine levels in human serum. Journal of Chromatography. 565:1991;441-446.
16. Kahn S.E., Prigeon R.L., McCulloch D.K., et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 42:1993;1663-1672.
17. Bar-On H., Kidron M., Friedlander Y., et al. Plasma total homocysteine levels in subjects with hyperinsulinemia. Journal of Internal Medicine. 247:2000;287-294.
18. Abbasi F., Facchini F., Humphreys M.H., Reaven G.M. Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin-mediated glucose disposal. Atherosclerosis. 146:1999;175-178.
19. Godsland I.F., Rosankiewicz J.R., Proudler A.J., Johnston D.G. Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men. Journal of Clinical Endocrinology and Metabolism. 86:2001;719-723.
20. Giltay E.J., Hoogeveen E.K., Elbers J.M., Gooren L.J., Asscheman H., Stehouwer C.D. Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects. Atherosclerosis. 139:1998;197-198.
21. Gallistl S., Sudi K., Mangge H., Erwa W., Borkenstein M. Insulin is an independent correlate of plasma homocysteine levels in obese children and adolescents. Diabetes Care. 23:2000;1348-1352.
22. Obarzanek E., Hunsberger S.A., Van H., et al. Safety of a fat-reduced diet: the Dietary Intervention Study in Children (DISC). Pediatrics. 100:1997;51-59.
23. Oshaug A., Bugge K.H., Refsum H. Diet, an independent determinant for plasma total homocysteine. A cross sectional study of Norwegian workers on platforms in the North Sea. European Journal of Clinical Nutrition. 52:1998;7-11.
24. Jacques P.F., Selhub J., Bostom A.G., Wilson P.W., Rosenberg I.H. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. New England Journal of Medicine. 340:1999;1449-1454.
25. Sheu W.H., Lee W.J., Chen Y.T. Plasma homocysteine concentrations and insulin sensitivity in hypertensive subjects. American Journal of Hypertension. 13:2000;14-20.
26. Meigs J.B., Jacques P.F., Selhub J., et al. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care. 24:2001;1403-1410.
27. Emoto M., Kanda H., Shoji T., et al. Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. Diabetes Care. 24:2001;533-538.
28. Brattstrom L., Wilcken D.E. Homocysteine and cardiovascular disease: cause or effect. American Journal of Clinical Nutrition. 72:2000;315-323. see comments, review, 139 references.